SpecOpt: Contact-Diff Reasoning for Agentic Molecule Optimization Toward Binding Specificity
Leveraging contact-differential reasoning to refine drug selectivity and reduce off-target protein interactions.
Off-target protein binding is a major source of adverse effects for small-molecule drugs, yet most structure-based molecular design methods focus on generating selective compounds de novo rather than improving the selectivity of existing, well- characterized drugs. We introduce s...
ArXiv CS.AI
Source
Generated insight by OnAirToday AI
SpecOpt introduces a novel contact-differential reasoning approach that shifts the focus from de novo generation to refining the specificity of existing drugs. This capability drastically reduces adverse side effects by minimizing off-target binding, representing a significant leap forward in precision pharmacology.
Comments
Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.